Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2018

01-10-2018 | Research Article

Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs

Authors: Vincent Giannetti, Charles F. Caley, Khalid M. Kamal, Jordan R. Covvey, Jerry McKee, Barbara G. Wells, Dean M. Najarian, Tyler J. Dunn, Pratyusha Vadagam

Published in: International Journal of Clinical Pharmacy | Issue 5/2018

Login to get access

Abstract

Background Half of Americans experience mental illness during their lifetime. Significant opportunity exists for community pharmacists to deliver services to these patients; however, personal and practice-related barriers may prevent full engagement. Objective To assess the demographics, practice characteristics, service provision, stigma, attitudes and beliefs of a national sample of community pharmacists towards individuals with mental illness. Setting National random sample of 3008 community pharmacists in the USA. Method 101-item cross-sectional mailed survey questionnaire on: (1) demographics, (2) knowledge and practice characteristics, (3) provision of clinical pharmacy services, and (4) comparative opinions. Main outcome measure Scaled measures of service provision (comfort, confidence, willingness and interest) and comparative opinions (stigma, attitudes and beliefs) of mental illness, four linear regression models to predict service provision. Results A total of 239 responses were received (response rate 7.95%). Across pharmacy services, ratings for willingness/interest were higher than those for comfort/confidence. Pharmacists who reported providing medication therapy management (MTM) services for patients reported higher comfort (18.36 vs. 17.46, p < 0.05), confidence (17.73 vs. 16.01, p < 0.05), willingness (20.0 vs. 18.62, p < 0.05) and interest (19.13 vs. 17.66, p < 0.05). Pharmacists with personal experience with mental illness also resulted in higher scores across all four domains of service provision, lower levels of stigma (18.28 vs. 20.76, p < 0.05) and more positive attitudes (52.24 vs. 50.53, p < 0.01). Regression analyses demonstrated increased frequency of MTM service delivery and more positive attitudes as significantly predictive across all four models for comfort, confidence, willingness and interest. Increased delivery of pharmacy services was significantly associated with both willingness and interest to provide mental illness-specific services. Conclusion Despite willingness/interest to provide services to patients with mental illness, decreased levels of comfort/confidence remain service-related barriers for community pharmacists.
Appendix
Available only for authorised users
Literature
2.
go back to reference Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, et al. Mental illness surveillance among adults in the United States. MMWR. 2011;60:Suppl 1–29. Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, et al. Mental illness surveillance among adults in the United States. MMWR. 2011;60:Suppl 1–29.
9.
go back to reference Calogero S, Caley CF. Supporting patients with MI: deconstructing barriers to community pharmacist access. J Am Pharm Assoc. 2003;2017(57):248–55. Calogero S, Caley CF. Supporting patients with MI: deconstructing barriers to community pharmacist access. J Am Pharm Assoc. 2003;2017(57):248–55.
10.
go back to reference O’Reilly CL, Bell JS, Kelly PJ, Chen TF. Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Res Soc Adm Pharm. 2015;11:e101–9.CrossRef O’Reilly CL, Bell JS, Kelly PJ, Chen TF. Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Res Soc Adm Pharm. 2015;11:e101–9.CrossRef
11.
go back to reference Rickles NM, Dube GL, McCarter A, Olshan JS. Relationship between attitudes toward MI and provision of pharmacy services. J Am Pharm Assoc. 2003;2010(50):704–13. Rickles NM, Dube GL, McCarter A, Olshan JS. Relationship between attitudes toward MI and provision of pharmacy services. J Am Pharm Assoc. 2003;2010(50):704–13.
12.
go back to reference Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medications. Psychiatr Serv. 2004;55:1434–6.CrossRef Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medications. Psychiatr Serv. 2004;55:1434–6.CrossRef
13.
go back to reference Murphy AL, Phelan H, Haslam S, Martin-Misener R, Kutcher SP, Gardiner DM. Community pharmacists’ experiences in MI and addictions care: a qualitative study. Subst Abuse Treat Prev Policy. 2016;11:6.CrossRef Murphy AL, Phelan H, Haslam S, Martin-Misener R, Kutcher SP, Gardiner DM. Community pharmacists’ experiences in MI and addictions care: a qualitative study. Subst Abuse Treat Prev Policy. 2016;11:6.CrossRef
14.
go back to reference Gardner DM, Murphy AL, Woodman AK, Connelly S. Community pharmacy services for antidepressant users. Int J Pharm Pract. 2001;9:217–24.CrossRef Gardner DM, Murphy AL, Woodman AK, Connelly S. Community pharmacy services for antidepressant users. Int J Pharm Pract. 2001;9:217–24.CrossRef
15.
go back to reference Hoch MA, Ott CA, Hudmon KS, Plake KS. Attitudes of individuals with schizophrenia towards pharmacists. J Am Pharm Assoc. 2003;2012(52):783–6. Hoch MA, Ott CA, Hudmon KS, Plake KS. Attitudes of individuals with schizophrenia towards pharmacists. J Am Pharm Assoc. 2003;2012(52):783–6.
16.
go back to reference Knox K, Fejzic J, Mey A, Fowler JL, Kelly F, McConnell D, et al. Mental health consumer and caregiver perceptions of stigma in Australian community pharmacies. Int J Soc Psychiatry. 2014;60:533–43.CrossRef Knox K, Fejzic J, Mey A, Fowler JL, Kelly F, McConnell D, et al. Mental health consumer and caregiver perceptions of stigma in Australian community pharmacies. Int J Soc Psychiatry. 2014;60:533–43.CrossRef
17.
go back to reference Thornicroft G. Most people with MI are not treated. Lancet. 2007;370:807–8.CrossRef Thornicroft G. Most people with MI are not treated. Lancet. 2007;370:807–8.CrossRef
18.
go back to reference Barney LJ, Griffiths KM, Jorm AF, Christensen H. Stigma about depression and its impact on help-seeking intentions. Aust NZ J Psychiatry. 2006;40:51–4.CrossRef Barney LJ, Griffiths KM, Jorm AF, Christensen H. Stigma about depression and its impact on help-seeking intentions. Aust NZ J Psychiatry. 2006;40:51–4.CrossRef
20.
go back to reference Thornicroft G, Rose D, Kassam A, Sartorius N. Stigma: ignorance, prejudice or discrimination? Br J Psychiatry. 2007;190:192–3.CrossRef Thornicroft G, Rose D, Kassam A, Sartorius N. Stigma: ignorance, prejudice or discrimination? Br J Psychiatry. 2007;190:192–3.CrossRef
21.
go back to reference Scheerder G, De Coster I, Van Audenhove C. Community pharmacists’ attitude toward depression: a pilot study. Res Social Adm Pharm. 2009;5:242–52.CrossRef Scheerder G, De Coster I, Van Audenhove C. Community pharmacists’ attitude toward depression: a pilot study. Res Social Adm Pharm. 2009;5:242–52.CrossRef
22.
go back to reference Kassam A, Papish A, Modgill G, Patten S. The development and psychometric properties of a new scale to measure MI related stigma by health care providers: the opening minds scale for health care providers (OMS-HC). BMC Psychiatry. 2012;12:62.CrossRef Kassam A, Papish A, Modgill G, Patten S. The development and psychometric properties of a new scale to measure MI related stigma by health care providers: the opening minds scale for health care providers (OMS-HC). BMC Psychiatry. 2012;12:62.CrossRef
23.
go back to reference Liekens S, Smits T, Laekeman G, Foulon V. Factors determining social distance toward people with depression among community pharmacists. Eur Psychiatry. 2012;27:528–35.CrossRef Liekens S, Smits T, Laekeman G, Foulon V. Factors determining social distance toward people with depression among community pharmacists. Eur Psychiatry. 2012;27:528–35.CrossRef
24.
go back to reference Dipaula BA, Qian J, Mehdizadegan N, Simoni-Wastila L. An elective psychiatric course to reduce pharmacy students’ social distance toward people with severe MI. Am J Pharm Educ. 2011;75:72.CrossRef Dipaula BA, Qian J, Mehdizadegan N, Simoni-Wastila L. An elective psychiatric course to reduce pharmacy students’ social distance toward people with severe MI. Am J Pharm Educ. 2011;75:72.CrossRef
25.
go back to reference Dillman DA. Mail and internet surveys: a tailored design method. New York: Wiley; 2000. p. 178–81. Dillman DA. Mail and internet surveys: a tailored design method. New York: Wiley; 2000. p. 178–81.
26.
go back to reference Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs: Prentice-Hall; 1963. p. 41–3. Goffman E. Stigma: notes on the management of spoiled identity. Englewood Cliffs: Prentice-Hall; 1963. p. 41–3.
27.
go back to reference Hogg MA, Vaughan GM. Social psychology. 8th ed. London: Pearson; 2018. p.154–61. Hogg MA, Vaughan GM. Social psychology. 8th ed. London: Pearson; 2018. p.154–61.
29.
go back to reference Maslen CL, Rees L, Redfern PH. Roles of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract. 1996;4:187–95.CrossRef Maslen CL, Rees L, Redfern PH. Roles of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract. 1996;4:187–95.CrossRef
30.
go back to reference Bell JS, Whitehead P, Aslani P, Sacker S, Chen TF. Design and implementations of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ. 2006;70:28.CrossRef Bell JS, Whitehead P, Aslani P, Sacker S, Chen TF. Design and implementations of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ. 2006;70:28.CrossRef
31.
go back to reference Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11:10967–90.CrossRef Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11:10967–90.CrossRef
32.
go back to reference Mey A, Fowler JL, Knox K, Shum DHK, Fejzic J, Hattingh L, et al. Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J. 2014;50:59–67.CrossRef Mey A, Fowler JL, Knox K, Shum DHK, Fejzic J, Hattingh L, et al. Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J. 2014;50:59–67.CrossRef
33.
go back to reference Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2003;2013(53):390–9. Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2003;2013(53):390–9.
34.
go back to reference Task Force on Specialty Recognition of Psychopharmacy Practice. Executive summary of petition requesting recognition of psychopharmacy. Am J Hosp Pharm. 1991;48:1284–90. Task Force on Specialty Recognition of Psychopharmacy Practice. Executive summary of petition requesting recognition of psychopharmacy. Am J Hosp Pharm. 1991;48:1284–90.
35.
go back to reference Marken PA, Evans RL. Survey of psychopharmacy curricula and faculty at schools of pharmacy. Am J Pharm Educ. 1993;57:330–2. Marken PA, Evans RL. Survey of psychopharmacy curricula and faculty at schools of pharmacy. Am J Pharm Educ. 1993;57:330–2.
36.
go back to reference Dopheide JA, Bostwick JR, Goldstone LW, Gable K, Thomas KL, Cates ME, et al. A 2015 survey of pharmacy curriculum in psychiatry and neurology in the United States. J Pharm Pract. 2016;29:274. Dopheide JA, Bostwick JR, Goldstone LW, Gable K, Thomas KL, Cates ME, et al. A 2015 survey of pharmacy curriculum in psychiatry and neurology in the United States. J Pharm Pract. 2016;29:274.
37.
go back to reference Martello JL, Kreys TJ, Paxos C, Thornton A. Survey of psychiatric pharmacy education at US schools of pharmacy. Curr Pharm Teach Learn. 2016;8:782–7.CrossRef Martello JL, Kreys TJ, Paxos C, Thornton A. Survey of psychiatric pharmacy education at US schools of pharmacy. Curr Pharm Teach Learn. 2016;8:782–7.CrossRef
38.
go back to reference Cates ME, Monk-Tutor MR, Drummond SO. Mental health and psychiatric pharmacy instruction in US colleges and schools of pharmacy. Am J Pharm Educ. 2007;71:4.CrossRef Cates ME, Monk-Tutor MR, Drummond SO. Mental health and psychiatric pharmacy instruction in US colleges and schools of pharmacy. Am J Pharm Educ. 2007;71:4.CrossRef
41.
go back to reference Gable KN, Muhlstadt KL, Celio MA. A mental health elective to improve pharmacy students’ perspectives on MI. Am J Pharm Educ. 2011;75:34.CrossRef Gable KN, Muhlstadt KL, Celio MA. A mental health elective to improve pharmacy students’ perspectives on MI. Am J Pharm Educ. 2011;75:34.CrossRef
42.
go back to reference Patten SB, Remillard A, Phillips L, Modgill G, Szeto ACH, Kassam A, et al. Effectiveness of contact-based education for reducing MI-related stigma in pharmacy students. BMC Med Educ. 2012;12:120.CrossRef Patten SB, Remillard A, Phillips L, Modgill G, Szeto ACH, Kassam A, et al. Effectiveness of contact-based education for reducing MI-related stigma in pharmacy students. BMC Med Educ. 2012;12:120.CrossRef
43.
go back to reference Nguyen E, Chen TF, O’Reilly CL. Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students. Soc Psychiatry Psychiatr Epidemiol. 2012;47:1087–98.CrossRef Nguyen E, Chen TF, O’Reilly CL. Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students. Soc Psychiatry Psychiatr Epidemiol. 2012;47:1087–98.CrossRef
46.
go back to reference Hinshaw SP. The mark of shame: stigma of MI and an agenda for change. New York: Oxford University Press; 2009. p. 202–16. Hinshaw SP. The mark of shame: stigma of MI and an agenda for change. New York: Oxford University Press; 2009. p. 202–16.
47.
go back to reference Whitley R, Berry S. Trends in newspaper coverage of MI in Canada: 2005–2010. Can J Psychiatry. 2013;58:107–12.CrossRef Whitley R, Berry S. Trends in newspaper coverage of MI in Canada: 2005–2010. Can J Psychiatry. 2013;58:107–12.CrossRef
48.
go back to reference Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59:1155–60.CrossRef Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59:1155–60.CrossRef
51.
go back to reference Meterko M, Restuccia JD, Stolzmann K, Mohr D, Brennan C, Glasgow J, et al. Response rates, nonresponse bias, and data quality: results from a national survey of senior healthcare leaders. Public Opin Q. 2015;79:130–44.CrossRef Meterko M, Restuccia JD, Stolzmann K, Mohr D, Brennan C, Glasgow J, et al. Response rates, nonresponse bias, and data quality: results from a national survey of senior healthcare leaders. Public Opin Q. 2015;79:130–44.CrossRef
Metadata
Title
Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs
Authors
Vincent Giannetti
Charles F. Caley
Khalid M. Kamal
Jordan R. Covvey
Jerry McKee
Barbara G. Wells
Dean M. Najarian
Tyler J. Dunn
Pratyusha Vadagam
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0619-7

Other articles of this Issue 5/2018

International Journal of Clinical Pharmacy 5/2018 Go to the issue